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in a Potential Organ Donor Affect the Outcome of Liver 
Transplantation? 
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The widespread application of hepatic transplantation has created a 
tremendous demand for donor organs. An assessment 01 donor 
parameters is thought to be important in selecting good donors; 
however, the criteria utilized have not been standardized. This study 
was performed to determine the effect of a measurable donor blood 
alcohol level on graft survival. Fifty-two patients who underwent 
orthotopic liver transplantation at the University of Pittsburgh were 
included in the study. Twenty-five patients received liver grafts from 
donors having a blood alcohol level between 0.04 and 0.4 g/I with a 
mean of 0.17 g/1. Twenty-seven patients received a liver graft from 
a donor who had no measurable blood alcohol. There were no 
differences between these two groups of donors regarding the time 
of initial hospitalization until the time of donation. Graft failure within 
the first 30 days was 24% for those receiving an organ from an 
alcohol-positive donor as compared with 22.2% in those receiving 
an organ from an alcohol negative donor. The recipient mortality rate 
was 16% and 11%, respectively. No relationships between the donor 
blood alcohol level and organ performance, Irequency of primary 
graft non function. or number of episodes of acute cellular rejection 
were evident. Based upon these data, the presence 01 a measurable 
blood alcohol level in a donor should not mitigate against organ 
donation. 
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H EPATIC TRA:\SPLA:\TA TlO:\ is the ultimate ther-
apeutic option in the clinical management of mam 
hepatic diseases. i.: It currently is ayDailahle~ at many cente~s 
worldwide and its Widespread application has created a 
tremendous demand for donor organs. A paucity of donor 
organs has always been an important problem limiting the 
full application ofliwr transplantation.; As the indications 
for li\er transplantation ha\e been expanded and the 
numher of indi\iduals with liwr disease waiting to be 
transplanted has expanded. the paucit~ of donor organs 
has become ewn more problematIC.! One approach to 
this problem has been the utilization of donors that pre-
Viously \\t'rc reJected because of their age. vascular insta-
bility. and confoundlOg medical illnesses such as diabetes 
and alcohol abuse." 
Despite such changes in the acceptahility of potential 
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donors. the continuous expansion of the pool of recipients 
has not been matched by an equivalent expansion of the 
pool of available donor organs. This discrepancy between 
the number of acceptable donors and recipients has lead 
to and continues to result in recipients dying while waiting 
to be transplanted. On the other hand. transplantation of 
unsound organs can lead to the unnecessary death of 
recipients or an accelerated need for retransplantation.:1 
As a result. attempts to assess the quality of potential liver 
donors has become an important function of organ pro-
curement organizations and transplant surgeons. < How-
ever. the criteria utilized by different centers have not been 
standardized nor haw previous attempts to correlate do-
nor characteristics with subsequent transplantation out-
come been particularly successfulK~ Even if an accurate 
assessment of donor hepatic function were possible prior 
to organ procurement. the subsequent events (e.g .. pres-
ervation and reperfusion injury) may be over-riding issues 
limiting donor organ function following engraftment.' 
Many donors die as a result of motor vehicle accidents. 
intracranial hemorrhage. head injury. aspiration and drug 
intoxication.' Ethanol intoxication is encountered fre-
quently in many of these same situations. Recently. it has 
been shown that donor livers with histologic macrowsi-
clllar steatosis function less well than do those with micro-
vesicular steatosis and as a result use of these grafts is 
associated with a greater freq uency of subsequent graft 
nonfunction.' Alcohol abuse is a common cause of hepatic 
macrowsicular steatosis." The following study was initi-
ated therefore to determine the effect of an elevated donor 
blood alcohol level obtained at the time of hospitahzation 
of the donor on hepatic graft survival following liver 
transplantation. 
MATERIALS AND METHODS 
.'>llIdl l'ol'lIl(1Ii(l// 
One hundred fift\ con<,ccutl\T donor>" rt'cord .. frum the lDnlylDr~ltI of 
mlll~hurgh· .. orgK~n pn)cun:mcn! OmCL' were re\ I(,wed n:tros!X'cII leh hc-
g.lnnlng on March I'JX'! and continuing through Decemncr ~ I. IlJX'J. 
Onl\ 44.7<", 111 = ()') had their oluod alcohol I<'\el determined. and thu~ 
tht" remaining dllnor~ could not 01.' included In thc stud:-. 1 hlm-I()ur 
dE}nor~ with a detl'ctahk olood akohollrvel at the time of ho\pitaillallon 
.... ere Idcntdird and .. ('ned a, the stud\ group SIX of the<,e WCrt' ndudc'd 
from suh~qucnt study a, thclr organs were transplantcd Into rlDuplf:nt~ 
undlDr!!oln~ relransplantatlon. Three additIOnal donor .. "cre eliminated 




stud' hecause they were utilized a~ pan of a multiviseeral trans-
from . . 
lant3tlOn procedure. 
P The second group consisted ofthm~-threedonors who had undete('\-
I blood alcohol In'cls at the time of their initial hospitalization: thu~ 
ab e conS1Jtutcd the control group. Six of these donors were excluded ~~ 'from subsequent stud~ hecause their organs were utilIzed h\ reClplent~ 
dergoing rctransplantatlOn procedures In five cases. and the organ of 
~:e sixth was used as pan of a multivisceral transplantation procedurc. 
The donor varia hies that were assessed for each group as factors 
ssihl\' relevant to subsequent successful graft function were the donors' :e. gender. reason for hospitalization. time interval from hospital!zatlOn 
. 0 actual donation. blood ethanol level. serum aspartate transaminase 
;SGOTl. serum alanine transaminase (SGPTI. total billruhin level. and 
the prothrombin time. 
The recipients' records were reviewed as well with particular attention 
being given to the age. sex. pnmary liver disease. back table biopsy 
!indtngs. postrevasculanzatlon liver bIOpsy findings. initial graft function. 
graft survival. and recipients survival within the first 30 days follOWing 
transplantation. 
Del/Ill! in/11 
Pnmary graft nonfunction Emd~F was defined as irreversihle failure 
of the graft to function occumng within 7 da\s of transplantation for 
which no other cause could he identified. 
Acute cellular reJection was defined as a mononuclear portal tract 
inflammation with e\ldence of bile duct damage wah or without sub-
endothehal inflammation. ", 
ChroniC rejection was defined as loss of small hile ducts and artenes 
or artenal mural thickening and hyalinization." 
IschemIC changes were defined as the presence of fine mlCroveslcular 
steatosis with an accumulation of neutrophil" In the slnusOids ncar 
cellular dehris associated wah central hepatocanaitcular cholestam' 
SWlisflCOi Anain/.I 
Results arc reponed as mean values ±SEM. ASSOCiations and differ-
ences in proportIOns were anahzed using Chi square test. Fisher's exart 
test was used as required: 2-wa\ anahsis of \ anancr wa<, used to test 
differences In mean "alues of the continuous \anahles. The eStimated 
surVIvals were calculated and compared uSing gcneraitzcd savage (Man-
tel-Coxi and Wilcoxon (Brenslow) Life Tahir analYSIS uSing the BMDP-
2L stallslical soflwarc package (L'ni\ersll\ of California I -\!, value of 
<0.05 wa<, conSidered to he statlsticall~ Significant. 
RESULTS 
Of the 25 recipients receiving an organ from a donor 
known to have a measurable blood lewl alcohol at time 
of initial hospitalization. 12 were males and 13 were 
female and their mean age was 44.1 ± 1_0 years. The 25 
donors consisted of 19 males and six females with a mean 
age of 16.4 ± 1.3 years. Fourteen of the :5 recipients 
received a donor organ that was gender matched. while 
nine female recipients received grafts from male donors 
and two males received their grafts from female donors. 
These donors could be divided into three groups based 
upon the level of blood ethanol at the time of initial 
hospitalization: 
Group I (II = 8). serum ethanol level <0. I 
gil (x = 0.07 ± 0.01) 
Group 2 (11 = 4). serum ethanol level O. 11-
0.19 gil (x = 0.14 ± 0.01) 
Group 3 (n = 13). serum ethanol level >0.2 
gil (x = 0.24 ± 0.0 I) 
Twenty-seven recipients received organs from donors 
without measurable blood alcohol levels at the time of 
initial hospitalization_ Nineteen of the recipients were 
male and eight were female with a mean age of 49.9 ± 2.5 
years. The 27 donors consisted of 15 males and 12 females 
with a mean age of 30.9 ± 2.4 years. Gender matching 
between the donor and the recipient occurred in 21 cases. 
while in six there was a mismatch with five males receiving 
a graft from a female donor and only one female who 
received a male liver graft. 
The donor characteristics of the two groups are shown 
in Table I. The characteristics of each group are segregated 
into those present in donors whose organs ultimately failed 
and those that functioned following surgical engraftment. 
No statistical differences were noted between the various 
groups. Table 2 shows the graft outcome for both donor 
groups further segregated as to the cause of graft injury 
following surgical engraftment. Again_ no differences 
among graft outcome categories in the two groups were 
evident. Tahle J shows the data for graft outcome of those 
organs obtained from donors with a measurable blood 
alcohol level divided into categories based upon the blood 
alcohol level in the donor at the time of initial hospitali-
zation. No statistical differences were evident for any 
specific cause of graft failure or for graft survival (Figs. I B 
and 2 B) as a function of the blood alcohol lew! 
Table 4 segregates failed grafts in the alcohol positive 
Table 1. Characteristics of the Two Donor Groups 
Graft 
Group outcome 
Alcohol,posltlve Graft failure 
n = 25 No failure 
Aicohol-fre€ Graft failure 
n = 27 No failure 
Norma! values 
• 4 Primary graft nontunctlon 
2 Humoral relectlon 
t 2 Primary gran nonfunctlon 
2 Humoral rejection 
, HepatiC artery thromOOSls 
Number Age 
(n) (yrs) 
6' 23:: 1 7 
19 28 :!: 1.5 
5t 31 = 24 
22 31 :: 29 
Time un iii Total Prothrombin 
donalion 5GOT SGPT Othrubln time 
(dayS) (IU/IJ (lUll) (mg/dl) (seconds) 
26= 07 79 = 226 33 :!: 8 07 :!: 0.2 14:: 0.7 
26:: 04 93 = 169 48 = 13 0.6:!: 0.1 14 :!: 03 
56=1.4 61 = 18 33:!: 6 0.8:!: 0 1 13 ± 0.5 
40 :!: 0.7 47 :!: 76 39:!: 9 0.7 ± 0 1 13 ± 03 
0-32 0-32 <1.0 12.0 
302 
T.ble 2. Graft Outcome In the Two Groups Studied 
Primary graft Humoral Cellular No 
nonfunctlon rejectIOn rejection Ischelma dysfunctoon 
Alcohol-posItIve 
n = 25 
Alcot101-free 
16% (4/25) 8% (2/25) 44°,o (11/25) 4~M (1/25) 28°'0 (7/25) 
7 4% (2/27) 0°,0 48,1 (13/27) 7,4 (2/27) 373°,0 (10127) 
n 27 
T.ble 3. Graft Outcome tor Those ReceIvIng a Gratt from a Donor wltn a 
Measurable Blood Alcohol Level Segregated as to the Level of Blood Alcohol 
Blood Primary gratt Humoral Cellular No 





12.5% (1/8) 0% 62.5% (SIB) 0% 
25% (1/4) 50% (2/4) 0°0 
25°,o (2/8) 
25% (114) 
>0,2 g/I 23,1% (3/13) 7,7°/0 (1/13) 30,7% (4/13) 7,7°'° (1/13) 307% 14/13) 
n = 13 
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Fig. 1. Kaplan Meyer survIVal curves for reaptents (A) and gratts (B) 01 the two 
donor groups studoea 
and alcohol free groups into groups based upon the timing 
of graft failure following transplantation. Again no differ-
ence between groups was evident. The ultimate recipient 
outcome for the alcohol free and alcohol positive groups 
experiencing primary nonfunction was 0)( and OR~ mor-
tality rate. respectively. A higher death rate was noted in 
those receiving an organ from an alcohol positive donor. 
but because of the small number. this difference was not 
significant. The recipient mortality as a function of having 
received a donor organ from an alcohol free or alcohol 
positive donor was 16% vs II %: no statistical difference 
between these groups was demonstrable (Fig. I A l. Finally 
recipient survival for those receiving an organ from an 
alcohol positive donor segregated as to the amount of 
HASSANEIN ET AL 





~ •...... , ................. ~~KI .................... -.....•................•.. 
eo ' ..... -,," -@ ~IK@-~ --0-. 
, 
.... •••••••••••••• .. •••• .. ••• .. • ...... ••• ..... •• .. ·oiIt 
oo~~~--~~~~==~=c~ __ ~~~ 
o • • • 1" 10 11 12 
Month, aller trinapiantatlon 
Gralt aUlVlvl1 Fig. 28 
lMMD------------rf~o~===I~l~===O~l=~~==D~~===II-----------1 
!.:..! ~i"K ~K~~? '!o!!.!! 
.. 
~Ki-~---i--~--iK--~K--~K--~qi-~K---i--~fK---fiI--~IO· 
Montha Ifter tranaplantatlon 
Fig. 2. Kaplan Meyer survival curves for recipIents (A) and grafts (B) of the two 
donor group studIed 
Table 4. TimIng of Graft Failure within the Forst 30 Days FollOWIng OL Tx 
Alcohol-posItIve 
n = 25 
Alcohol-tree 
n = 27 
16-30 
1-15 Days Days Total 
20% (5125) 4°;0 (1/25) 24% (6/25) 
148% (4/27) 3.7% (2/27) 22.2°/0 (6/27) 
Table 5. Reapoent Mortality among IndIVIduals ReceIVIng an Alcohol PosItIve 
Donor Segregated as to Level of Blood Alcohol 
Expored 
Alive 
n=8 n=4 n=13 





Table 6. Back Table and Post anastomosIs Graft B,opsy 
Alcot101 ~roua 
(n = 5J 
Control ~roup 
(n = 7) 
Histopathology Back table Postanastomosls Back table Postanastorroosis 
Normal boops y 5 3 10 11 
SteatosIs 
MICrO 6 4 6 3 
Macro 3 2 7 3 
M,xed 5 3 2 
Ischemia 
Mild 4 6 2 2 
Moderate 2 4 4 
Severe 3 2 
25 25 27 27 
alcohol found in the donor is shown in Table 5 and Fig. 
2A. Again_ no statistical differences was evident. Histo· 
logic findings for backtable and post-revascularization 
graft biopsies are summarized in Table 6 and presented as 
, 
EFFECT OF BLOOD DONOR ALCOHOL ON LIVER GRAFT OUTCOME 
grOUP finding as follows: 
Alcoho!-Positi\,(' Groll!, 
In eight of the alcohol-positive organs. some histological 
deterioration of the graft biops?' followin~ reperfusion was 
noted. Five of these grafts ultImately failed: four due to 
primary graft nonfunction and one due to acu~e humoral 
rejection. In c.ontrast. among the 17 alcohol-po.sltIve donor 
Organs in which no apparent change In the liver appear-
ance occurred following reperfusion. no graft failures were 
seen (Table 6). 
Alcohol-(re(' Groll!, 
In seven. some deterioration in the histologic appear-
ance of the graft was demonstrable following reperfusion: 
twO of these seven grafts failed as a result of primary graft 
nonfunction. 
DISCUSSION 
This study demonstrates that recipients of organs ob-
tained from alcohol positive donors do equally following 
OLTx as do those obtained from donors who are alcohol-
free. Further. higher donor blood alcohol levels are not 
associated with a poorer outcome in terms of graft dys-
function of any type. the frequency of primary graft fail-
ure. ultimate graft survival or recipient survival. Receiving 
a graft from a donor of a different gender had no effect on 
the outcome of the transplant. 
Typically. donors of organs utilized for transplantation 
are individuals who are young. die suddenly and unex-
pectedly. usually as a result of an accident or injury.' 
Alcohol use is common in individuals who possess these 
particular characteristics. Thus. alcohol users/abusers as a 
group are over represented among organ donors. 
Alcoholism IS a common problem. In the United States 
alone. it is estimated that there are 9 million or more 
alcohol abusers. 10 Moreover. alcoholic liver disease is the 
9th leading cause of death in the United States and occurs 
predominantly in those in their 3rd through Slh decades 
of life. typically the most productive years of an individ-
JO.1 
uars life. I 1.11 This time period also coincides with the ages 
at which most donors are recruited. 
Despite their numbers. individuals with ;la'anccd al-
coholic liver disease have been considered only recently 
as possible candidates for OL Tx. Thus. taken as a group. 
alcohol abusers have been and continue to he under-
represented as recipients of liver transplants while at the 
same time being over represented in the donor popula-
tion.4 
REFERENCES 
I. Stanl TE. Demetris AJ. Van Thiel DH: Liver transplantallon (first 
of two pans). N Engl J Med 321 (15): 1014-1022. 1978 
2. Maddrey We. Van Thiel DH: Livertransplantation: An overview. 
Hepatology 8:948-959. 1988 
3. Ascher NL: Selection criteria for liver transplantation donors. 
Transplant Proc 21:3482-3483.1989 
4. Schenker S. Perkins HS. Sorrell MF: Should patients wlth end 
stage alcoholic liver disease have a new liver? Hepato1og\ 11:-' 14-319. 
1990 
5. Makowka L. Gordon RD. Todo S. Ohkohchi )\;. Marsh JW. Tzakls 
AG. YOkOi H. Ligush J. Esquivel CO. Satske M. Iwatsukl S. Stan I TE: 
Analysis of donor criteria for the prediction df outcome in clinical liver 
transplantation. Transplant Proc 19:2378-2382. 1987 
6. Mimeault R. Grant D. Ghent e. DutT J. Wall W: Analysis of donor 
and reCipient vanables and early graft function after orthotopIC liver 
transplantation. Transplant Proc 21:3355. 1989 
7. Mora NP. Tumon VS. Pardo F. Pereira F. Herrera J. Ardaiz J. 
Olwares P. MurCia J. Vazquez J. Cienfuegos JA: Relevance of donor 
li ver selectIOn and graft viability In a liver transplantation program. 
Transplant Proc 20:978-979.1988 
8. Kakizoe S. Yanaga K. Starzl TE. Demetris J: Evaluation of pro-
tocol pre-transplant and post-reperfusion bIOpSies from human ortho-
topic liver allografts: Consideration of "preservation" and immunologIC 
mjury. Hepatolog\ (in press) 
9. Blendls LM. Orrego H. Crossle\ JR. Blake JE. Medllnt A. Israel 
Y: The role of hepatoc~1e enlargement in hepatic pressure In CirrhotiC 
and non-cirrhotic alcoholic liver disease. Hepatology 2:534-54(,. 1982 
10. Demetris AJ. Qlan S. Sun H. Fung JJ: Liver allograft rejection: 
An o\erview of morphologic findings. Am J Surg Pathol 1449-63. 1990 
II. Brooks SD. Williams GD. Stinson FS. "oble J: NIAAA Surveil-
lance Report "10 13: Apparent per capita alcohol consumption: ~:ltfonalK 
state and regional trends. 1977-1987. Washington DC US Department 
of Health and Human Services. Public Health Service. Alcohol Drug 
Ahuse Mental Health Administration. Septemhcr. 19~4 
12. Grant BF. wohcc~ TS: N1AAA Surveillance Report No II: Liver 
cirrhOSIS monality in the United States. 1972-1988. Washington DC: 
US Department of Health and Human Services. Alcohol Drug Ahuse 
Mental Health Administration. June. 19~4 
